137 related articles for article (PubMed ID: 38323655)
1. Effectiveness of opioid switching for dyspnea and its predictors in cancer patients: a single-center retrospective observational study.
Yamamoto Y; Tanaka S; Matsuura K; Yamamoto S; Urano K; Okita J; Kato E; Odagiri T; Deguchi Y
Jpn J Clin Oncol; 2024 May; 54(5):549-555. PubMed ID: 38323655
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
[TBL] [Abstract][Full Text] [Related]
3. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
Maeda T; Hayakawa T
J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
[TBL] [Abstract][Full Text] [Related]
4. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
[TBL] [Abstract][Full Text] [Related]
5. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
[TBL] [Abstract][Full Text] [Related]
6. Opioids for Relief of Dyspnea Immediately Before Death in Patients With Noncancer Disease: A Case Series Study.
Murakami M
Am J Hosp Palliat Care; 2019 Aug; 36(8):734-739. PubMed ID: 30803242
[TBL] [Abstract][Full Text] [Related]
7. Effect of continuous intravenous oxycodone infusion in opioid-naïve cancer patients with dyspnea.
Yamamoto Y; Watanabe H; Sakurai A; Deguchi Y; Hirano S; Okumura Y; Kumon A; Watanabe N; Osada T; Yamamura K; Odagiri T
Jpn J Clin Oncol; 2018 Aug; 48(8):748-752. PubMed ID: 29893883
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
9. Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study.
Yamaguchi T; Matsunuma R; Matsuda Y; Tasaki J; Ikari T; Miwa S; Aiki S; Takagi Y; Kiuchi D; Suzuki K; Oyamada S; Ariyoshi K; Kihara K; Mori M
J Pain Symptom Manage; 2023 May; 65(5):400-408. PubMed ID: 36641006
[TBL] [Abstract][Full Text] [Related]
10. Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series.
Gauna AA; Kang SK; Triano ML; Swatko ER; Vanston VJ
J Palliat Med; 2008 May; 11(4):643-8. PubMed ID: 18454622
[TBL] [Abstract][Full Text] [Related]
11. Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer.
Matsumura C; Yamada M; Fujihara S; Chisaki Y; Takahashi K; Yano Y
Am J Hosp Palliat Care; 2016 Mar; 33(2):109-14. PubMed ID: 25324418
[TBL] [Abstract][Full Text] [Related]
12. Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial.
Hui D; Kilgore K; Frisbee-Hume S; Park M; Liu D; Balachandran DD; Bruera E
J Pain Symptom Manage; 2017 Dec; 54(6):798-805. PubMed ID: 28803087
[TBL] [Abstract][Full Text] [Related]
13. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
14. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer.
Pinna MÁ; Bruera E; Moralo MJ; Correas MÁ; Vargas RM
Am J Hosp Palliat Care; 2015 May; 32(3):298-304. PubMed ID: 24259406
[TBL] [Abstract][Full Text] [Related]
15. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Poor Pain Control after Opioid Switching from Oxycodone Tablet to Fentanyl Patch.
Morikawa N; Kasahara Y; Takahashi Y; Nishikura K; Nishihara M
Biol Pharm Bull; 2019; 42(10):1674-1678. PubMed ID: 31582655
[TBL] [Abstract][Full Text] [Related]
17. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
18. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
19. [Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients].
Naito T; Kawakami J
Yakugaku Zasshi; 2015; 135(5):709-15. PubMed ID: 25948306
[TBL] [Abstract][Full Text] [Related]
20. Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial.
Hui D; Kilgore K; Park M; Williams J; Liu D; Bruera E
J Pain Symptom Manage; 2016 Oct; 52(4):459-468.e1. PubMed ID: 27401508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
